Target Name: Gamma-glutamyl transferase
NCBI ID: P11206
Review Report on Gamma-glutamyl transferase Target / Biomarker Content of Review Report on Gamma-glutamyl transferase Target / Biomarker
Gamma-glutamyl transferase
Other Name(s): GGT

GGT: A Versatile Enzyme with A Wide Range of Applications

Gamma-glutamyl transferase (GGT) is a enzyme that is involved in the metabolism of a variety of compounds, including drugs, toxins, and other substances that are harmful to the body. GGT is a nonspecific enzyme, meaning that it is not limited to a specific type of substrate, and it is found in many different cells in the body.

One of the things that makes GGT an attractive drug target is its versatility. GGT can be activated by a wide variety of substances, including drugs, toxins, and other molecules that are harmful to the body. This means that GGT can be used as a drug indicator or a biomarker for a variety of different conditions.

In addition to its potential as a drug target, GGT is also a potential biomarker for a number of different diseases. For example, GGT is often elevated in individuals with liver disease, and it has been used as a biomarker for conditions such as cirrhosis and nonalcoholic steatohepatitis (NASH).

GGT is also involved in the metabolism of many different compounds, including drugs that are used to treat a wide range of diseases. For example, GGT is often used to metabolize drugs that are used to treat cancer, such as chemotherapy drugs and targeted therapies.

In addition to its potential as a drug target and biomarker, GGT is also an important enzyme in the body that helps to break down harmful substances. GGT is involved in the metabolism of a variety of compounds, including many toxins and other substances that are harmful to the body.

Overall, GGT is a versatile enzyme that has a wide range of potential applications in medicine and other fields. As research continues to advance, the potential uses for GGT as a drug target and biomarker will continue to grow.

Protein Name: Gamma-glutamyl Transferase (nonspecified Subtype)

The "Gamma-glutamyl transferase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Gamma-glutamyl transferase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

gamma-Secretase | Gamma-tubulin complex | GAMT | GAN | GANAB | GANC | Gap junction Connexin ( | Gap Junction Protein | GAP43 | GAPDH | GAPDHP1 | GAPDHP14 | GAPDHP21 | GAPDHP38 | GAPDHP42 | GAPDHP56 | GAPDHP62 | GAPDHP65 | GAPDHP72 | GAPDHS | GAPLINC | GAPT | GAPVD1 | GAR1 | GAREM1 | GAREM2 | GARIN1A | GARIN1B | GARIN2 | GARIN3 | GARIN4 | GARIN5A | GARIN5B | GARIN6 | GARNL3 | GARRE1 | GARS1 | GARS1-DT | GART | GAS1 | GAS1RR | GAS2 | GAS2L1 | GAS2L2 | GAS2L3 | GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH